MDM2 and liposarcoma: One common type of MDM2 alteration is its amplification, which often results in MDM2 protein overexpression and is observed in various malignancies, and the incidence of MDM2 amplification ranges from 0% (anaplastic and papillary carcinoma of thyroid) to 63.6% (liposarcoma) [19].